M&A Deal Summary |
|
|---|---|
| Date | 2012-01-31 |
| Target | BioReliance |
| Sector | Healthcare Services |
| Buyer(s) | Sigma-Aldrich |
| Sellers(s) |
Avista Healthcare Partners
The Carlyle Group |
| Deal Type | Add-on Acquisition |
| Deal Value | 350M USD |
| Advisor(s) | J.P. Morgan Securities (Financial) Weil Gotshal & Manges (Legal) |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Founded | 1951 |
| Sector | Life Science |
| Employees | 9,800 |
| Revenue | 2.8B USD (2014) |
Sigma-Aldrich Corp. is a life science and high technology company whose biochemical, organic chemical products, kits, and services are used in scientific research, including genomic and proteomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical, diagnostics and high technology manufacturing. Sigma-Aldrich customers include more than 1.3 million scientists and technologists in life science companies, university, and government institutions, hospitals, and industry.
| DEAL STATS | # |
|---|---|
| Overall | 10 of 13 |
| Sector (Healthcare Services) | 1 of 1 |
| Type (Add-on Acquisition) | 8 of 9 |
| State (Maryland) | 1 of 1 |
| Country (United States) | 7 of 9 |
| Year (2012) | 1 of 2 |
| Size (of disclosed) | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2010-12-30 |
Cerilliant
Round Rock, Texas, United States Cerilliant Corporation is a chemicals company that uses organic synthesis for the production of analytical reference standards used in medical, forensic, environmental, pharmaceutical and other test laboratories. Cerilliant has developed a worldwide reputation as a leading provider of analytical reference standards. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2012-04-02 |
Research Organics
Cleveland, Ohio, United States Research Organics, Inc., to expand the Company's buffer production capacity and to increase its portfolio of PharmaGrade raw materials for the biopharmaceutical and diagnostic markets. Research Organics is a leading supplier of high purity biochemicals for use in molecular biology, diagnostics, cell culture, pharmaceuticals, biopharmaceuticals, life sciences and biotechnology. |
Buy | - |
| Category | Private Equity Firm |
|---|---|
| Founded | 2005 |
| PE ASSETS | 8.0B USD |
| Size | Mega |
| Type | Sector Focused |
Avista Capital Partners is a private investment firm formed by a group of professionals with roots from DLJ Merchant Banking Partners. Avista makes controlling and minority investments in US based energy, healthcare, and media companies with revenues greater than $25 million. Typical transactions include leverage buyouts, build-ups, and growth capital financings. Avista Capital was formed in 2005 and is based in New York City with an additional office in Houston, Texas.
| DEAL STATS | # |
|---|---|
| Overall | 9 of 30 |
| Sector (Healthcare Services) | 2 of 3 |
| Type (Add-on Acquisition) | 5 of 15 |
| State (Maryland) | 1 of 1 |
| Country (United States) | 7 of 24 |
| Year (2012) | 2 of 4 |
| Size (of disclosed) | 9 of 11 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2012-01-31 |
Navilyst Medical
Marlborough, United States Navilyst Medical, Inc. is a provider of innovative solutions for image-guided interventions delivering superior outcomes and reducing healthcare costs for medical professionals and their patients. |
Sell | $372M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2012-05-02 |
Fougera Pharmaceuticals
Melville, New York, United States Fougera Pharmaceuticals Inc. operates two primary divisions in the US focused on specialty pharmaceuticals in dermatology: Fougera, its generic dermatology medicines business, and PharmaDerm, its branded dermatology business. Founded in 1849, the Fougera division is the leading manufacturer and distributor of a wide range of topical products. The PharmaDerm division is dedicated to developing and commercializing novel prescription products to treat diseases and conditions of the skin – the largest organ of the human body. |
Sell | $1.5B |
| Category | Private Equity Firm |
|---|---|
| Founded | 1987 |
| PE ASSETS | 435.0B USD |
| Size | Mega |
| Type | Sector Agnostic |
The Carlyle Group is a global investment firm that pursues private equity, credit, and real estate investments worldwide. Carlyle's private equity practice practice pursues buyouts, strategic minority equity investments, equity private placements, consolidations and buildups, and growth capital financings. With offices in 19 countries, Carlyle can easily target opportunities throughout North America, Europe, Asia, Australia, the Middle East/North Africa and Latin America. Broad sectors of interest include aerospace, defense, automotive and transportation, consumer, retail, energy and power, financial services, healthcare, industrial, infrastructure, technology services, business services, telecommunications and media. The Carlyle Group was formed in 1987 and is based in Washington DC.
| DEAL STATS | # |
|---|---|
| Overall | 192 of 481 |
| Sector (Healthcare Services) | 5 of 18 |
| Type (Add-on Acquisition) | 93 of 198 |
| State (Maryland) | 8 of 10 |
| Country (United States) | 127 of 259 |
| Year (2012) | 3 of 29 |
| Size (of disclosed) | 70 of 136 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2012-01-31 |
Babela Restaurant Management
Shanghai, China Babela Restaurant Management Co. Ltd. is a multi-branded restaurant platform with a significant footprint in Shanghai and Beijing. Babela, the company's flagship brand, is a Italian-themed casual dining chain with over 120 stores nationwide. The company also operates Bamboo Bifengtang, a Cantonese dim sum dining concept, and Aha, which are Taiwanese style dessert outlets. |
Sell | $40M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2012-02-03 |
Dynamic Offshore Resources
Houston, Texas, United States Dynamic Offshore Resources LLC is a provider of oil and gas exploration services in US. |
Sell | $1.3B |
